Spinal κ1 and κ2 opioid binding sites in rats, guinea pigs, monkeys and humans

NeuroReport

Volumn 9, Issue 11, 1998, Pages 2523-2525

  Caudle, Robert M ^a   Finegold, Alan A ^a   Mannes, Andrew J ^b   Tobias, Michael D ^b   Kenshalo Jr , Daniel R ^a   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Allodynia; Analgesia; Hyperalgesia; Kappa opioid receptors; Spinal cord

Indexed keywords

BREMAZOCINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; TRITIUM; ANALGESIC AGENT; BENZENEACETAMIDE DERIVATIVE; BENZOMORPHAN DERIVATIVE; PYRROLIDINE DERIVATIVE;

ALLODYNIA; ANALGESIA; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CHRONIC PAIN; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; HUMAN TISSUE; HYPERALGESIA; MONKEY; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SPINAL CORD; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; HISTOLOGY; IN VITRO STUDY; MACACA; MEMBRANE; METABOLISM;

ANALGESICS; ANIMALS; BENZENEACETAMIDES; BENZOMORPHANS; GUINEA PIGS; HUMANS; MACACA FASCICULARIS; MACACA MULATTA; MEMBRANES; PYRROLIDINES; RATS; RECEPTORS, OPIOID, KAPPA; SPECIES SPECIFICITY; SPINAL CORD;

EID: 0032479591     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199808030-00018     Document Type: Article

References (12)

1. Caudle RM, Mannes AJ and Iadarola MJ. J Pharmacol Exp Ther 283, 1342-1349 (1997).
2. Caudle RM, Chavkin C and Dubner RJ. Neuroscience 14, 5580-5589 (1994).
3. Mansour A, Hoversten MT, Taylor LP et al. Brain Res 700, 89-98 (1995).
4. Castillo PE, Salin PA, Weisskopf MG et al. J Neurosci 16, 5942-5950 (1996).
5. Drake CT, Terman GW, Simmons ML, Milner et al. J Neurosci 14, 3736-3750 (1994).
6. Wagner JJ, Caudle RM and Chavkin C. J Neurosci 12, 132-141 (1992).
7. Wagner JJ, Terman GW and Chavkin C. Nature 363, 451-454 (1993).
8. Weisskopf MG, Zalutsky RA and Nicoll RA. Nature 423-427 (1993).
9. H J, Mannes AJ, Dubner R et al. J Pharmacol Exp Ther 28 1136-142 (1997).
10. Nock B, Giordano AL, Moore BW and Cicero TJ. J Pharmacol Exp Ther 264, 349-359 (1993).
11. Ren K, Williams GM, Hylden JLK et al. Eur J Pharmacol 219, 235-243 (1992).
12. Schoffelmeer ANM, Hogenboom F and Mulder AH. Br J Pharmacol 122, 520-524 (1997).